背景与目的：C型肝性脑病（HE）患者表现出多种症状，表明不同脑区受到影响。理解这些区域特有的代谢与细胞变化可能有助于解释HE临床表现的变异性。我们首次分析了胆管结扎（BDL）大鼠模型在慢性肝病（CLD）进展过程中海马、纹状体和小脑的纵向体内神经代谢及形态学变化。方法：Wistar大鼠接受BDL手术，并在BDL前后以及术后第2、4、6和8周通过海马、纹状体和小脑的体内1H-MRS（9.4T）检测、组织学评估（星形胶质细胞、小胶质细胞和神经元）及血液生化分析进行研究。结果：在所有脑区中，谷氨酰胺（Gln）是最早增加的代谢物，随后是渗透压调节物质和神经递质的减少。小脑表现出最高的Gln负荷（+134%）、乳酸升高（+84%）和γ-氨基丁酸（GABA）降低（-23%），提示其更高的易感性。这与星形胶质细胞形态显著改变相关，可能与高Gln负荷有关。相比之下，纹状体的Gln增幅最低（+48%），但渗透压调节物质降幅最大，星形胶质细胞变化较轻。此外，我们还展示了小胶质细胞（激活）和神经元（树突棘密度下降、胞体大小改变）在各脑区中的共同和独特的形态学变化。结论：我们的研究揭示了脑区对CLD的共同及差异性代谢与细胞反应，小脑和纹状体表现出不同的响应。我们推测，谷氨酰胺是C型HE早期脑代谢标志物之一，影响星形胶质细胞并不可避免地影响神经元，导致认知功能下降。

Background & Aims: Patients with type C hepatic encephalopathy (HE) present diverse symptoms indicating that various brain regions are affected. Understanding the distinct metabolic and cellular changes across these regions could help explain the clinical variability of HE. We analyzed, for the first time, the longitudinal in-vivo neurometabolic and morphological changes in astrocytes, neurons and microglia in the hippocampus, striatum and cerebellum during the progression of CLD-induced type C HE in the bile duct ligated (BDL) rat model. Methods: Wistar rats underwent BDL and their brains were studied before BDL and at post-operative weeks-2, 4, 6 and 8 using in-vivo 1H-MRS (9.4T) of the hippocampus, striatum and cerebellum along with histological assessment (astrocytes, microglia, and neurons) and blood biochemistry. Results: Across all brain regions, glutamine (Gln) was the first metabolite to increase, followed by a decrease in osmolytes and neurotransmitters. The cerebellum was characterized by the highest Gln burden (+134%), elevated Lactate (+84%) and decreased GABA (-23%), suggesting its increased vulnerability. This coincided with pronounced alterations in astrocyte morphology, possibly related to the high Gln load. In contrast, the striatum displayed the lowest Gln increase (+48%) but the strongest osmolyte decrease, with milder astrocytic changes. We also showed mutual and distinct regional morphological changes in microglia (activation) and neurons (decreased dendritic spine density, soma size alterations). Conclusions: Our findings highlight both common and differential metabolic and cellular responses to CLD across the brain regions, with cerebellum and striatum showing differential responses. We also hypothesized that glutamine is one of the initial brain metabolic markers of type C HE, impacting astrocytes and inevitably neurons contributing to cognitive decline.